Deutsche Bank’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Sell |
14,488
-3,408
| -19% | -$63.5K | ﹤0.01% | 2785 |
|
|
2025
Q1 | $325K | Sell |
17,896
-2,115
| -11% | -$38.4K | ﹤0.01% | 2685 |
|
|
2024
Q4 | $436K | Buy |
20,011
+7,179
| +56% | +$157K | ﹤0.01% | 2645 |
|
|
2024
Q3 | $351K | Buy |
12,832
+3,363
| +36% | +$92.1K | ﹤0.01% | 2605 |
|
|
2024
Q2 | $245K | Buy |
+9,469
| New | +$245K | ﹤0.01% | 2657 |
|
|
2022
Q2 | – | Sell |
-1,087
| Closed | -$50K | – | 3989 |
|
|
2022
Q1 | $50K | Sell |
1,087
-121
| -10% | -$5.57K | ﹤0.01% | 3757 |
|
|
2021
Q4 | $85K | Buy |
1,208
+60
| +5% | +$4.22K | ﹤0.01% | 3698 |
|
|
2021
Q3 | $133K | Sell |
1,148
-34
| -3% | -$3.94K | ﹤0.01% | 3716 |
|
|
2021
Q2 | $185K | Buy |
1,182
+267
| +29% | +$41.8K | ﹤0.01% | 3786 |
|
|
2021
Q1 | $174K | Sell |
915
-79
| -8% | -$15K | ﹤0.01% | 3673 |
|
|
2020
Q4 | $125K | Buy |
994
+273
| +38% | +$34.3K | ﹤0.01% | 3652 |
|
|
2020
Q3 | $79K | Buy |
721
+161
| +29% | +$17.6K | ﹤0.01% | 3599 |
|
|
2020
Q2 | $68K | Buy |
560
+100
| +22% | +$12.1K | ﹤0.01% | 3593 |
|
|
2020
Q1 | $46K | Buy |
460
+21
| +5% | +$2.1K | ﹤0.01% | 3506 |
|
|
2019
Q4 | $105K | Buy |
439
+98
| +29% | +$23.4K | ﹤0.01% | 3487 |
|
|
2019
Q3 | $55K | Sell |
341
-29
| -8% | -$4.68K | ﹤0.01% | 3772 |
|
|
2019
Q2 | $87K | Sell |
370
-647
| -64% | -$152K | ﹤0.01% | 4128 |
|
|
2019
Q1 | $266K | Buy |
1,017
+895
| +734% | +$234K | ﹤0.01% | 3755 |
|
|
2018
Q4 | $10K | Sell |
122
-449
| -79% | -$36.8K | ﹤0.01% | 4472 |
|
|
2018
Q3 | $110K | Sell |
571
-679
| -54% | -$131K | ﹤0.01% | 4302 |
|
|
2018
Q2 | $270K | Buy |
+1,250
| New | +$270K | ﹤0.01% | 4050 |
|